These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


89 related items for PubMed ID: 3205259

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. S-phase cell detection with a monoclonal antibody.
    Miltenburger HG, Sachse G, Schliermann M.
    Dev Biol Stand; 1987; 66():91-9. PubMed ID: 3556275
    [Abstract] [Full Text] [Related]

  • 23. DNA denaturation sensitivity may invalidate bromodeoxyuridine--DNA flow cytometric analysis of potential doubling times in colorectal tumours.
    Gilliland R, Williamson KE, Hamilton PW, Crockard A, Spence RA.
    Br J Surg; 1997 Feb; 84(2):242-7. PubMed ID: 9052447
    [Abstract] [Full Text] [Related]

  • 24. [Flow cytometric measurements of in vivo incorporated bromodeoxy- uridine into the DNA of experimental and human tumors].
    Kärcher H, McNally NJ, Wilson G, Kärcher KH, Pfragner R.
    Wien Klin Wochenschr; 1985 Nov 22; 97(22):850-5. PubMed ID: 4082602
    [Abstract] [Full Text] [Related]

  • 25. [Studies on cell cycle analysis using a monoclonal antibody to bromodeoxyuridine (BrdU labeling method)].
    Fujikane T, Shimizu T.
    Nihon Gan Chiryo Gakkai Shi; 1988 Jul 20; 23(7):1538-50. PubMed ID: 3183461
    [No Abstract] [Full Text] [Related]

  • 26. Cell kinetic studies of in situ human brain tumors with bromodeoxyuridine.
    Hoshino T, Nagashima T, Murovic J, Levin EM, Levin VA, Rupp SM.
    Cytometry; 1985 Nov 20; 6(6):627-32. PubMed ID: 2998714
    [Abstract] [Full Text] [Related]

  • 27. A short history of the initial application of anti-5-BrdU to the detection and measurement of S phase.
    Leif RC, Stein JH, Zucker RM.
    Cytometry A; 2004 Mar 20; 58(1):45-52. PubMed ID: 14994219
    [No Abstract] [Full Text] [Related]

  • 28. Flow cytometric determination with bromodeoxyuridine/DNA assay of sensitivity of S-phase cells to cytosine arabinoside in childhood acute lymphoblastic leukemia.
    Katano N, Tsurusawa M, Niwa M, Fujimoto T.
    Am J Pediatr Hematol Oncol; 1989 Mar 20; 11(4):411-6. PubMed ID: 2618975
    [Abstract] [Full Text] [Related]

  • 29. Application of an ELISA procedure for the quantitation of bromodeoxyuridine incorporated into cellular DNA.
    Cheitlin RA, Bodell WJ.
    Anticancer Res; 1988 Mar 20; 8(3):471-4. PubMed ID: 3389750
    [Abstract] [Full Text] [Related]

  • 30. Cytokinetic investigation of lung tumors using the anti-bromodeoxyuridine (BUdR) monoclonal antibody method: comparison with DNA flow cytometric data.
    Teodori L, Trinca ML, Goehde W, Hemmer J, Salvati F, Storniello G, Mauro F.
    Int J Cancer; 1990 Jun 15; 45(6):995-1001. PubMed ID: 2161804
    [Abstract] [Full Text] [Related]

  • 31. In vitro immunohistochemical localization of S-phase cells by a monoclonal antibody to bromodeoxyuridine.
    Risio M, Coverlizza S, Poccardi G, Candelaresi GL, Gaiola O.
    Basic Appl Histochem; 1986 Jun 15; 30(4):469-77. PubMed ID: 3548696
    [Abstract] [Full Text] [Related]

  • 32. Immunocytochemical demonstration of S phase cells by anti-bromodeoxyuridine monoclonal antibody in human prostate adenocarcinoma.
    Nemoto R, Uchida K, Shimazui T, Hattori K, Koiso K, Harada M.
    J Urol; 1989 Feb 15; 141(2):337-40. PubMed ID: 2643726
    [Abstract] [Full Text] [Related]

  • 33. A monoclonal antibody reactive with 5-bromo-2-deoxyuridine that does not require DNA denaturation.
    Gonchoroff NJ, Greipp PR, Kyle RA, Katzmann JA.
    Cytometry; 1985 Nov 15; 6(6):506-12. PubMed ID: 3905299
    [Abstract] [Full Text] [Related]

  • 34. [Cell kinetics in human anagen hair and hair follicles studied with bromodeoxyuridine (BrdU) and anti-BrdU monoclonal antibody].
    Egawa K, Yoshimura K, Kageshita T, Ono T.
    Nihon Hifuka Gakkai Zasshi; 1988 Jan 15; 98(1):61-4. PubMed ID: 3043063
    [No Abstract] [Full Text] [Related]

  • 35. [Cell kinetic effects of cis-platinum on cancer cells in a culture system and in cases of cervical cancer using monoclonal antibody of BrdU].
    Izutsu T, Hirama T, Matsuda M, Yoshizumi N, Kagabu T, Nishiya I.
    Gan To Kagaku Ryoho; 1989 Apr 15; 16(4 Pt 2-3):1834-41. PubMed ID: 2730076
    [Abstract] [Full Text] [Related]

  • 36. Flow-cytometry DNA index of colorectal carcinomas.
    Pandrea IR, Zugun F, Târcoveanu E, Diaconu C, Mihailovici MS, Carasevici E.
    Rev Med Chir Soc Med Nat Iasi; 1995 Apr 15; 99(1-2):112-5. PubMed ID: 9524666
    [Abstract] [Full Text] [Related]

  • 37. Cell cycle analysis using flow cytometry.
    Gray JW, Dolbeare F, Pallavicini MG, Beisker W, Waldman F.
    Int J Radiat Biol Relat Stud Phys Chem Med; 1986 Feb 15; 49(2):237-55. PubMed ID: 3510993
    [Abstract] [Full Text] [Related]

  • 38. Antibodies to proliferating cell nuclear antigen as S-phase probes in flow cytometric cell cycle analysis.
    Landberg G, Roos G.
    Cancer Res; 1991 Sep 01; 51(17):4570-4. PubMed ID: 1678682
    [Abstract] [Full Text] [Related]

  • 39. Cytometric ploidy and proliferative activity in colorectal carcinoma.
    Grigolato P, Berenzi A, Benetti A, Chirico E, Cadei M, Casella C, Salerni B, Lojacono L.
    Eur J Histochem; 1994 Sep 01; 38(2):163-70. PubMed ID: 7524813
    [Abstract] [Full Text] [Related]

  • 40. High-resolution multi-parameter DNA flow cytometry enables detection of tumour and stromal cell subpopulations in paraffin-embedded tissues.
    Corver WE, Ter Haar NT, Dreef EJ, Miranda NF, Prins FA, Jordanova ES, Cornelisse CJ, Fleuren GJ.
    J Pathol; 2005 Jun 01; 206(2):233-41. PubMed ID: 15822070
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.